REQUEST A DEMO
Total
USD $0.00
Search more companies

Allucent D.O.O. (Serbia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Allucent D.O.O. Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Allucent D.O.O. is based in Serbia, with the head office in Belgrade. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was established on February 12, 2015. The total number of employees is currently 58 (2024). In its most recent financial highlights, the company reported a net sales revenue drop of 5.9% in 2024. During that time, Allucent D.O.O.’s total assets grew by 36.85%. In, 2024, the company’s net profit margin decreased by 0.23%.

Headquarters
Djordja Stanojevica 14
Belgrade; Belgrade;

Contact Details: Purchase the Allucent D.O.O. report to view the information.

Basic Information
Total Employees:
Purchase the Allucent D.O.O. report to view the information.
Registered Capital:
Purchase the Allucent D.O.O. report to view the information.
Financial Auditors:
Purchase the Allucent D.O.O. report to view the information.
Incorporation Date:
February 12, 2015
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
99.8051%
Purchase this report to view the information.
0.1949%
Company Performance
Financial values in the chart are available after Allucent D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-5.9%
Total operating revenue
-5.9%
Operating profit (EBIT)
-5.37%
EBITDA
-5.48%
Net Profit (Loss) for the Period
-11.04%
Total Assets
36.85%
Total Equity
9.68%
Operating Profit Margin (ROS)
0.03%
Net Profit Margin
-0.23%
Return on Equity (ROE)
-2.55%
Quick Ratio
-2.67%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?